| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $176,834,680 ) (Continued on the next page) |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG062826 | Subjective Cognitive Decline in OIder Adults | 000 | 5 | NIH | 1/26/2024 | $736,228 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K24AI148459 | Mentoring in transmission of influenza and strategies for prevention | 000 | 5 | NIH | 1/26/2024 | $178,602 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI151210 | Macrophage mitochodrial reprogramming and innate immune memory | 000 | 5 | NIH | 1/18/2024 | $382,466 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI145992 | Defining the impact of host factors on the molecular architecture and bacterial physiology of Staphylococcus aureus abscesses | 000 | 5 | NIH | 2/29/2024 | $646,808 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01MH121620 | 1/3-Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-life Depression (Rembrandt) | 000 | 5 | NIH | 11/29/2023 | $720,394 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K08HL150282 | Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations | 000 | 6 | NIH | 1/4/2024 | $148,716 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS113832 | Biophysical basis of functional MRI of white matter | 001 | 5 | NIH | 4/11/2024 | $34,981 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01NS113832 | Biophysical basis of functional MRI of white matter | 000 | 5 | NIH | 1/10/2024 | $449,796 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL144568 | Automated Abdominal Binder for Orthostatic Hypotension | 000 | 5 | NIH | 12/14/2023 | $475,952 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01NS110661 | Relational Memory as a Model of Behavioral (Dys)Function in Adults with Traumatic Brain Injury | 000 | 5 | NIH | 2/19/2024 | $560,572 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI150701 | The Staphylococcus aureus response to nutrient zinc restriction during infection | 000 | 5 | NIH | 1/5/2024 | $382,122 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG061161 | Cognitive and Physical Exercise to Improve Outcomes after Surgery in the Elderly | 000 | 5 | NIH | 2/16/2024 | $729,596 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01ES031401 | Manganese exposure susceptibility as a modifier of excitotoxicity in Alzheimer's Disease | 000 | 5 | NIH | 10/23/2023 | $535,556 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG065249 | Early Cognitive Training and Rehabilitation to Prevent Cognitive Decline in Older Hospitalized Adults with Delirium | 003 | 4 | NIH | 2/14/2024 | $546,688 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K24AI150349 | Mentoring Investigators in HIV and Tuberculosis Therapeutics Research | 000 | 5 | NIH | 1/10/2024 | $175,826 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01MH121455 | Distinguishing Clinical and Genetic Risk of Suicidal Ideation from Attempts to Inform Prevention | 000 | 5 | NIH | 10/25/2023 | $489,362 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DC017926 | Language Processing in Context Following Traumatic Brain Injury | 000 | 5 | NIH | 11/7/2023 | $582,188 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA237895 | Time-dependent and bidirectional effect of oxidative stress - a missing piece of the free radical theory of cancer and its potential implications | 001 | 5 | NIH | 4/16/2024 | $34,219 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01CA237895 | Time-dependent and bidirectional effect of oxidative stress - a missing piece of the free radical theory of cancer and its potential implications | 000 | 5 | NIH | 11/30/2023 | $615,943 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI149722 | Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity | 000 | 5 | NIH | 12/6/2023 | $472,843 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 001 | 5 | NIH | 11/8/2023 | $370,546 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 001 | 5 | NIH | 11/8/2023 | $607,495 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01FD006649 | Prospective Development of a Multimodal Biomaker Platform for Predictive Risk Stratification of Cardiac Disease in Duchenne Muscular Dystrophy | 000 | 4 | FDA | 3/18/2024 | $675,698 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U01DK123716 | Human Pancreas Analysis Program-T2D | 000 | 5 | NIH | 1/25/2024 | $989,999 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI141448 | Cell Intrinsic Immune Control of KSHV | 000 | 5 | NIH | 11/14/2023 | $382,122 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL144846 | Sex-Specific Risk of Metabolic and Cardiovascular Disease | 001 | 5 | NIH | 3/12/2024 | $676,286 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | H3331540 | EMSC PARTNERSHIP GRANTS | 00 | 8 | HRSA | 3/21/2024 | $83,352 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R35HL144980 | Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia | 000 | 6 | NIH | 2/8/2024 | $918,000 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UG1CA233270 | Vanderbilt Network Lead Academic Participating Site for the NCTN | 001 | 6 | NIH | 4/18/2024 | $24,364 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UG1CA233270 | Vanderbilt Network Lead Academic Participating Site for the NCTN | 000 | 6 | NIH | 2/27/2024 | $438,548 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG058639 | BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study | 000 | 5 | NIH | 1/25/2024 | $2,839,648 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | H7630761 | EARLY INTERVENTION SERVICES | 00 | 9 | HRSA | 3/13/2024 | $194,448 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS108445 | MRI Connectivity Biomarkers of Treatment Response in Focal Epilepsy | 001 | 5 | NIH | 4/11/2024 | $29,607 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01NS108445 | MRI Connectivity Biomarkers of Treatment Response in Focal Epilepsy | 000 | 5 | NIH | 1/10/2024 | $380,683 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI143710 | The effectiveness of RSV immunoprophylaxis on the short- and long- term respiratory morbidity in children with Down syndrome | 000 | 6 | NIH | 1/23/2024 | $403,280 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R35HL140016 | Mechanisms of Immune Activation in Hypertension | 000 | 7 | NIH | 12/6/2023 | $676,365 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA217987 | Metabolic barriers to T cell activation in clear cell renal cell carcinoma | 004 | 7 | NIH | 4/17/2024 | $26,906 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA217987 | Metabolic barriers to T cell activation in clear cell renal cell carcinoma | 003 | 7 | NIH | 3/27/2024 | $484,288 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R35HL140025 | Biochemistry and Pathophysiology of Factor XI and Contact Activation | 000 | 7 | NIH | 12/14/2023 | $711,000 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | TL1TR002244 | NRSA Training Core | 001 | 8 | NIH | 4/13/2024 | $645,717 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UL1TR002243 | Vanderbilt Institute for Clinical and Translational Research (VICTR) | 001 | 8 | NIH | 3/22/2024 | $9,858,660 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | KL2TR002245 | Institutional Career Development Core | 001 | 8 | NIH | 3/30/2024 | $1,103,336 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI118932 | Type IV Protein Secretion in Helicobacter pylori | 000 | 10 | NIH | 3/22/2024 | $714,887 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01NS092961 | Resting State Connectivity in Primate Spinal Cord | 000 | 10 | NIH | 2/14/2024 | $506,305 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K12HD087023 | Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease | 001 | 10 | NIH | 3/22/2024 | $438,716 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | RM1HG009034 | Genetic Privacy and Identity in Community Settings: CEER Final Meeting Administrative Supplement | 000 | 8 | NIH | 2/22/2024 | $82,563 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01EY024373 | Regulation of Eye Morphogenesis | 000 | 7 | NIH | 3/27/2024 | $475,404 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL122554 | Androgens inhibit IL-33 production and airway inflammation | 000 | 10 | NIH | 2/7/2024 | $605,942 |
| | 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01EY024997 | Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma | 001 | 8 | NIH | 12/22/2023 | $455,525 |
|
